Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196
|
CN |
|
C
|
Central Glass Co Ltd
TSE:4044
|
JP |
|
Infragreen Group Ltd
ASX:IFN
|
AU |
|
Vardhman Textiles Ltd
NSE:VTL
|
IN |
|
Anfield Energy Inc
XTSX:AEC
|
CA |
|
K
|
Kilroy Realty Corp
F:KRC
|
US |
|
Fresenius SE & Co KGaA
MIL:FRE
|
DE |
|
A
|
Aqua Bio Technology ASA
OSE:ABTEC
|
NO |
|
Fomento de Construcciones y Contratas SA
MAD:FCC
|
ES |
|
D
|
Delta Air Lines Inc
BMV:DAL
|
US |
|
Nihon M&A Center Holdings Inc
OTC:NHMAF
|
JP |
|
Wallbridge Mining Company Ltd
TSX:WM
|
CA |
Dividends
Dividend Yield
Shanghai Fosun Pharmaceutical Group Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Shanghai Fosun Pharmaceutical Group Co Ltd
Shanghai Fosun Pharmaceutical Group Co Ltd have decreased by 0%.
Payout Ratio
Shanghai Fosun Pharmaceutical Group Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Shanghai Fosun Pharmaceutical Group Co Ltd is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Shanghai Fosun Pharmaceutical Group Co Ltd
| Average Annual Return | -12.78% |
| Standard Deviation of Annual Returns | 15.71% |
| Max Drawdown | -64% |
| Market Capitalization | 61B CNY |
| Shares Outstanding | 2 557 379 400 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Shanghai Fosun Pharmaceutical Group Co Ltd's latest stock split occurred on Jul 26, 2010
The company executed a 3-for-2 stock split, meaning that for every 2 shares held, investors received 3 new shares.
The adjusted shares began trading on Jul 26, 2010. This was stock split number 7 in Shanghai Fosun Pharmaceutical Group Co Ltd's history, following the previous one in Jun 8, 2007.